BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9359907)

  • 1. The action of perchlorate on malignant-hyperthermia-susceptible muscle.
    Anderson LC; Fruen BR; Jordan RC; Louis CF; Gallant EM
    Pflugers Arch; 1997 Dec; 435(1):91-8. PubMed ID: 9359907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced inhibitory effect of Mg2+ on ryanodine receptor-Ca2+ release channels in malignant hyperthermia.
    Laver DR; Owen VJ; Junankar PR; Taske NL; Dulhunty AF; Lamb GD
    Biophys J; 1997 Oct; 73(4):1913-24. PubMed ID: 9336187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ryanodine receptor in different malignant hyperthermia-susceptible porcine muscles.
    Ervasti JM; Strand MA; Hanson TP; Mickelson JR; Louis CF
    Am J Physiol; 1991 Jan; 260(1 Pt 1):C58-66. PubMed ID: 1824808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anions that potentiate excitation-contraction coupling may mimic effect of phosphate on Ca2+ release channel.
    Fruen BR; Mickelson JR; Roghair TJ; Cheng HL; Louis CF
    Am J Physiol; 1994 Jun; 266(6 Pt 1):C1729-35. PubMed ID: 8023902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of perchlorate on the molecules of excitation-contraction coupling of skeletal and cardiac muscle.
    Ma J; Anderson K; Shirokov R; Levis R; González A; Karhanek M; Hosey MM; Meissner G; Ríos E
    J Gen Physiol; 1993 Sep; 102(3):423-48. PubMed ID: 8245818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia.
    Mickelson JR; Gallant EM; Litterer LA; Johnson KM; Rempel WE; Louis CF
    J Biol Chem; 1988 Jul; 263(19):9310-5. PubMed ID: 3379071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excitation-contraction coupling in pigs heterozygous for malignant hyperthermia.
    Gallant EM; Lentz LR
    Am J Physiol; 1992 Feb; 262(2 Pt 1):C422-6. PubMed ID: 1539630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant hyperthermia and excitation-contraction coupling.
    Melzer W; Dietze B
    Acta Physiol Scand; 2001 Mar; 171(3):367-78. PubMed ID: 11412150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant hyperthermia: effects of sarcoplasmic reticulum Ca2+ pump inhibition.
    Enzmann NR; Balog EM; Gallant EM
    Muscle Nerve; 1998 Mar; 21(3):361-6. PubMed ID: 9486865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [4-chloro-m-cresol-induced contractures of skeletal muscle specimen from patients at risk for malignant hyperthermia].
    Wappler F; Scholz J; von Richthofen V; Fiege M; Steinfath M; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Sep; 32(9):541-8. PubMed ID: 9417254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation and inhibition of [3H]ryanodine binding to sarcoplasmic reticulum from malignant hyperthermia susceptible pigs.
    Mickelson JR; Litterer LA; Jacobson BA; Louis CF
    Arch Biochem Biophys; 1990 Apr; 278(1):251-7. PubMed ID: 2321964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of perchlorate on depolarization-induced conformational changes in the junctional foot protein and Ca2+ release from sarcoplasmic reticulum.
    Yano M; el-Hayek R; Ikemoto N
    Biochemistry; 1995 Oct; 34(39):12584-9. PubMed ID: 7548007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered E-C coupling in triads isolated from malignant hyperthermia-susceptible porcine muscle.
    el-Hayek R; Yano M; Antoniu B; Mickelson JR; Louis CF; Ikemoto N
    Am J Physiol; 1995 Jun; 268(6 Pt 1):C1381-6. PubMed ID: 7611356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.
    Lacava C; Michalek-Sauberer A; Kraft B; Sgaragli G; Sipos E; Höller C; Kress HG; Fusi F; Weigl LG
    Pharmacol Res; 2012 Jul; 66(1):80-7. PubMed ID: 22480578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calmodulin sensitivity of the sarcoplasmic reticulum ryanodine receptor from normal and malignant-hyperthermia-susceptible muscle.
    O'Driscoll S; McCarthy TV; Eichinger HM; Erhardt W; Lehmann-Horn F; Herrmann-Frank A
    Biochem J; 1996 Oct; 319 ( Pt 2)(Pt 2):421-6. PubMed ID: 8912676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal ryanodine receptor channels in malignant hyperthermia.
    Fill M; Coronado R; Mickelson JR; Vilven J; Ma JJ; Jacobson BA; Louis CF
    Biophys J; 1990 Mar; 57(3):471-5. PubMed ID: 2306496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstitution of abnormalities in the malignant hyperthermia-susceptible pig ryanodine receptor.
    Shomer NH; Louis CF; Fill M; Litterer LA; Mickelson JR
    Am J Physiol; 1993 Jan; 264(1 Pt 1):C125-35. PubMed ID: 7679249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloride-dependent sarcoplasmic reticulum Ca2+ release correlates with increased Ca2+ activation of ryanodine receptors.
    Fruen BR; Kane PK; Mickelson JR; Louis CF
    Biophys J; 1996 Nov; 71(5):2522-30. PubMed ID: 8913591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine malignant hyperthermia: halothane effects on force generation in skeletal muscles.
    Gallant EM; Goettl VM
    Muscle Nerve; 1989 Jan; 12(1):56-63. PubMed ID: 2747737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in ryanodine-induced contractures by stimulus frequency in malignant hyperthermia susceptible and malignant hyperthermia nonsusceptible dog skeletal muscle.
    Sudo RT; Nelson TE
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1331-6. PubMed ID: 9316843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.